X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PLETHICO PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PLETHICO PHARMA SANOFI INDIA/
PLETHICO PHARMA
 
P/E (TTM) x 32.9 -1.1 - View Chart
P/BV x 6.3 0.0 37,434.6% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 SANOFI INDIA   PLETHICO PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
PLETHICO PHARMA
Mar-14
SANOFI INDIA/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,560395 1,154.7%   
Low Rs4,40031 14,057.5%   
Sales per share (Unadj.) Rs1,028.5604.4 170.2%  
Earnings per share (Unadj.) Rs129.032.5 397.1%  
Cash flow per share (Unadj.) Rs186.051.3 362.3%  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.6473.6 159.1%  
Shares outstanding (eoy) m23.0334.08 67.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.40.4 1,235.4%   
Avg P/E ratio x34.76.6 529.5%  
P/CF ratio (eoy) x24.14.2 580.2%  
Price / Book Value ratio x5.90.5 1,321.0%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,1747,262 1,420.7%   
No. of employees `0003.6NA-   
Total wages/salary Rs m3,5921,596 225.1%   
Avg. sales/employee Rs Th6,537.7NM-  
Avg. wages/employee Rs Th991.4NM-  
Avg. net profit/employee Rs Th819.8NM-  
INCOME DATA
Net Sales Rs m23,68620,598 115.0%  
Other income Rs m708386 183.3%   
Total revenues Rs m24,39420,984 116.2%   
Gross profit Rs m5,2812,818 187.4%  
Depreciation Rs m1,313642 204.4%   
Interest Rs m151,593 0.9%   
Profit before tax Rs m4,661969 481.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691-138 -1,222.0%   
Profit after tax Rs m2,9701,107 268.3%  
Gross profit margin %22.313.7 163.0%  
Effective tax rate %36.3-14.3 -253.9%   
Net profit margin %12.55.4 233.3%  
BALANCE SHEET DATA
Current assets Rs m15,67318,877 83.0%   
Current liabilities Rs m6,67811,896 56.1%   
Net working cap to sales %38.033.9 112.1%  
Current ratio x2.31.6 147.9%  
Inventory Days Days7636 211.5%  
Debtors Days Days22198 11.3%  
Net fixed assets Rs m8,0989,861 82.1%   
Share capital Rs m230341 67.6%   
"Free" reserves Rs m17,08812,331 138.6%   
Net worth Rs m17,35616,139 107.5%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m25,40033,146 76.6%  
Interest coverage x311.71.6 19,387.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.90.6 150.1%   
Return on assets %11.88.1 144.3%  
Return on equity %17.16.9 249.5%  
Return on capital %26.912.3 219.2%  
Exports to sales %24.521.4 114.6%   
Imports to sales %28.015.2 183.8%   
Exports (fob) Rs m5,8014,402 131.8%   
Imports (cif) Rs m6,6273,136 211.3%   
Fx inflow Rs m7,1454,402 162.3%   
Fx outflow Rs m6,8463,184 215.0%   
Net fx Rs m2991,219 24.5%   
CASH FLOW
From Operations Rs m3,2262,437 132.4%  
From Investments Rs m-1,555-6,265 24.8%  
From Financial Activity Rs m-1,8182,490 -73.0%  
Net Cashflow Rs m-147-1,337 11.0%  

Share Holding

Indian Promoters % 0.0 82.7 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 4.3 334.9%  
FIIs % 14.6 5.5 265.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 7.5 140.0%  
Shareholders   15,184 10,665 142.4%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jan 19, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS